解决社会风险,加快健康平等在癌症预防和控制
Jean A McDougall1, Theresa A Hastert2, Dede K Teteh3
1Office of Community Outreach and Engagement, Fred Hutchinson Cancer Research Center, Seattle, Washington.
概括
解决癌症预防和控制中的社会风险是实现癌症健康公平的关键. 本综述概述了当前的研究,并为针对癌症不平等的社会决定因素的干预提供了多层次的建议.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 健康 公平 研究 健康 公平 研究
背景情况:
- 社会风险对癌症预防和控制工作产生重大影响.
- 解决这些风险对于促进癌症健康公平至关重要.
- 美国预防性瘤学会 (ASPO) 癌症健康差异特别利益小组强调需要集中研究和实践.
研究的目的:
- 审查有关瘤学研究和实践中社会风险的科学现状.
- 为解决社会风险的多层次研究和干预提供建议.
- 确定减少因社会决定因素而产生的癌症不平等的策略.
主要方法:
- 关于瘤学中社会风险的当前研究的文献综述.
- 对干预开发的社会生态模型的分析.
- 综合研究和实践的建议在多个层面.
主要成果:
- 目前关于瘤学中的社会风险的研究正在不断发展.
- 需要多层次的干预措施来有效应对社会风险.
- 社会生态模型为有针对性的干预提供了一个框架.
结论:
- 将社会风险评估和干预整合到瘤学中,对于癌症健康公平至关重要.
- 未来的研究应该专注于多层次的策略,以减轻社会风险对癌症结果的影响.
- 需要跨人际,组织,社区和政策层面的协作努力来消除癌症不平等.
相关概念视频
Strategies for Assessing and Addressing Confounding
101
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
101
Cancer Survival Analysis
348
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
348
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Levels of Health Promotion and Illness Prevention
12.6K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
In primary prevention, actions taken before disease onset prevent the disease from...
12.6K
Cancer Vaccines
367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


